Instead, adopting a well-rounded approach to health and wellness can help patients effectively reduce abdominal fat while improving overall body composition
This strategy has been exploited in the long-acting GLP-1RA semaglutide (Novo Nordisk), for instance, which was approved for treatment of T2DM in 2017, and for treatment of obesity in 2021, and has since then become the most prescribed GLP-1RA 92
We are here to offer a comprehensive, telehealth-first experience that supports you every step of the way
F.CemekM.KaralarM.HaziniA.AlpdagtasS.et al (2014)
Ozempic or metformin for weight loss
Depauw PRAM, Groen RJM, Van Loon J et al (2019) The significance of intra-abdominal pressure in neurosurgery and neurological diseases: a narrative review and a conceptual proposal